About this trial

The project will aim to identify and determine subgroups of patients with different risks of progression to gastric cancer and to assess appropriate follow-up intervals. Implementing risk stratification only high risk individuals will be offered and performed endoscopic surveillance.

Eligibility criteria

Qualifiers

None

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Upper endoscopy with biopsies
  • Plasma/serum sampling
  • Biopsies for gastric microbiota
  • Faecal sample acquisition

Treatment groups

2,000 Participants
are divided into 7 treatment groups

7

Treatment groups

See each treatment group below.

Locations

1
University of LatviaLV 1586, Riga Latvia

Sponsors and collaborators

University of Latvia

Lead sponsor

Digestive Diseases Centre GASTRO

Collaborator

Riga East Clinical University Hospital

Collaborator

Academic Histology Laboratory (Latvia)

Collaborator